The global market for point-of-care molecular diagnostics is anticipated to expand at a CAGR of 8.5% during the forecast period of 2023 and 2031. The rise of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing desire of end users for point-of-care molecular testing due to its attractive features. Medical personnel has long utilized molecular diagnostics in laboratories and other healthcare settings.
The global optometry equipment market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024 to 2032. The rising technological advances in optometry equipment and the rising awareness of early disease diagnosis in developing nations are driving market expansion. Increasing awareness of eye care services has led to an increase in the number of eye care providers, necessitating differentiation of services in terms of new and innovative technology.
The global digital health market is expected to grow at a compound annual growth rate (CAGR) of 30% during the forecast period of 2023 and 2032. The term "digital health" refers to the use of information technology and electronic communications in various health care processes for improving people's overall health and well-being. The healthcare industry has seen a revolutionary transformation thanks to the quick uptake of cutting-edge technologies like artificial intelligence, mHealth applications, edible sensors, and wearable technology.
Phospholipase enzyme market is projected to reach 7.0% CAGR during the forecast period from 2024 to 2032. In 2021, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest-growing region between 2023 and 2032.
Cosmetic dentistry has emerged as one of the dynamic sectors within dental care, offering a plethora of treatments ranging from basic color correction to teeth replacement. The appeal of an enhanced smile and the advances in dental technology have ensured that cosmetic dentistry has remained in high demand. Cosmetic dentistry marketis estimated to grow at a CAGR of 13.3% from 2024 to 2032.
Hepatic Encephalopathy Therapeutics Market Is Projected to Expand At A CAGR Of 6.5% Between 2023 And 2031. As per the citing of the National Organization for Rare Diseases (NORD) 2016 report, hepatic encephalopathy is described as brain disorder in patients previously suffering with chronic liver ailments such as liver cirrhosis, hepatitis and acute liver failure.
The psoriatic arthritis treatment market is expected to grow at a CAGR of 8.2% during the forecast period of 2024 to 2032, fueled by several key factors that shape its dynamics. Advancements in drug class development, a shift towards the oral route of administration, and an evolving landscape of distribution channels are the primary drivers contributing to the market's expansion. The continuous progress in drug class development, including TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, and others, has significantly impacted the market.
GI Stool Testing Market Is Projected to Expand At A CAGR Of XX% Between 2023 And 2031. Stools tests are performed to diagnose the GI tract disorders and aid in the detection of parasites infection, bleeding obstruction, and inflammation. Stools tests can further be utilized for diagnosis of colorectal cancer or presence of pathogens such as Rotavirus, C. difficile, H. pylori among others in the GI tract.
Clot Management Devices Market Is Projected to Expand At A CAGR Of 4.2% Between 2023 And 2031. The global clot management devices market is expected to retain steady growth due to rising prevalence of peripheral artery diseases, venus thromboelbolism, coronary diseases and so on.
SAn extensive portfolio of vaccines and constant rising demand has rendered the vaccine contract manufacturing market to be highly competitive with vast presence of key players across geographies. Along with safety and effectiveness of vaccines, flooding the market with one’s product clutches equal importance. In order to cater to the rising demand for vaccines and maintaining uniform quality, leading industrial players tend to outsource manufacturing of vaccines to third parties to expedite market entry.
The market size for Healthcare Services was assessed at USD 10.3 Trillion in 2021 and is projected to reach USD 21.06 Trillion by 2030, expanding at a CAGR of 8.30% between 2022 and 2030. The market for healthcare services and technology is expanding fast, creating possibilities, hazards, and structural problems for enterprises in the industry and those in the healthcare value chain as a whole. Given that healthcare improvement potential exceeds $500 billion, the future growth potential of the healthcare services and technology business is considerable.
To establish frictionless markets for healthcare products and services, for instance, large-scale platform players could emerge. These participants could also become ecosystem integrators, integrating a variety of healthcare products and services, allowing consumers (patients and their families) to better manage their own healthcare.
The increase in the number of aged people, accelerated economic growth, technical advances, alterations in lifestyles, and improved ability to survive and level of living is anticipated to contribute to the expansion of the Healthcare Services Market. Raising the declaration of bundled payments, employing digital tools, expanding cross-industry and cross-company relationships, focusing on the creation of novel pharmaceuticals, and acquiring hybrid imaging techniques are all significant trends in the Healthcare Services Market. In recent decades, the price of medical facilities has climbed substantially.
Acute Market Reports' areas of expertise as a market research and strategic consulting organization have an undiluted focus on the healthcare service domain. Acute Market Reports' clients gain from our innovative and futuristic research methodology, which helps them make educated business decisions in a timely manner. In order to provide our international customers with innovative strategic research solutions, we engage with a wide range of industry participants.
